Clinical and Radiographic Outcome of Regeneration in Immature Permanent Human Teeth Using a New Scaffold

NCT ID: NCT06812351

Last Updated: 2025-02-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-22

Study Completion Date

2022-03-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to evaluate clinical and radiographic outcome of regeneration in immature permanent human teeth using two different types of scaffolds:

1. Collagen-hydroxyapatite scaffold (Osteon III collagen) after blood clot.
2. Conventional blood clot scaffold.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Randomized Clinical Trial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Scaffold with blood clot group

root canals were filled with Osteon III Collagen scaffold after blood clot induction during revascularization.

Group Type EXPERIMENTAL

Osteon III collagen

Intervention Type DRUG

Hydroxyapatite and tricalcium phosphate particles embeded in bovine collagen

blood clot group

root canals were filled with blood clot only after conventional revascularization procedure.

Group Type PLACEBO_COMPARATOR

Blood clot

Intervention Type BIOLOGICAL

Induction of bleeding from apical papilla

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Osteon III collagen

Hydroxyapatite and tricalcium phosphate particles embeded in bovine collagen

Intervention Type DRUG

Blood clot

Induction of bleeding from apical papilla

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Double antibiotic liquid

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Single rooted immature permanent teeth.
2. Symptoms:

1. Pulp necrosis either due to infection or trauma.
2. Periapical condition; tooth should have periapical radiolucency.
3. Tooth should be restorable without the need for further post placement.
4. Age: from 6-15 years.
5. Sex: males or females.
6. Preoperative Cone beam Computed tomography is a must.

Exclusion Criteria

* Teeth with complete root formation. 2. Teeth that are badly broken down with difficult isolation. 3. Medically compromised patients. 4. Periodontally affected teeth.
Minimum Eligible Age

6 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Menna Ali

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Abeer Abdelhakim El gendy, PhD

Role: STUDY_DIRECTOR

AinShams University

Maram Farouk Obeid, PhD

Role: STUDY_DIRECTOR

AinShams University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AinShams university

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RCT1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.